CalciMedica (CALC) News Today $2.07 +0.08 (+4.02%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$2.07 0.00 (0.00%) As of 03/27/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period CalciMedica Inc. Common StockMarch 27 at 9:39 AM | 247wallst.comCalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate UpdatesMarch 27 at 7:00 AM | prnewswire.comCalciMedica (CALC) Projected to Post Earnings on ThursdayMarch 20, 2025 | americanbankingnews.comCalciMedica Shares Drop After Securing New Credit FacilityMarch 5, 2025 | marketwatch.comCalciMedica Secures Credit Facility for Up to $32.5 MillionMarch 5, 2025 | prnewswire.comCalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT ConferenceMarch 4, 2025 | prnewswire.comCalciMedica, Inc. (CALC): Among Penny Stocks with Insider Buying in 2025March 4, 2025 | insidermonkey.comCalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT ConferenceFebruary 19, 2025 | prnewswire.comCalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 3, 2025 | prnewswire.comCalciMedica Announces Appointment of Dr. Alan Glicklich to Board of DirectorsJanuary 14, 2025 | prnewswire.comLUCID CAPITAL MARKETS Initiates Coverage of CalciMedica (CALC) with Buy RecommendationDecember 18, 2024 | msn.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Director Buys 4,800 Shares of StockDecember 7, 2024 | insidertrades.comComprehensive 2024 Insights into the Acute Pancreatitis Pipeline Treatment Landscape Featuring CalciMedica, SCM Lifescience, and Lamassu PharmaNovember 27, 2024 | finance.yahoo.comCalciMedica to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 21, 2024 | prnewswire.comCalciMedica Announces Presentations at Upcoming Medical MeetingsNovember 20, 2024 | prnewswire.comInsiders Bet Big on These Small Cap StocksNovember 14, 2024 | insidertrades.comCalciMedica, Inc.: CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesNovember 14, 2024 | finanznachrichten.deCalciMedica’s Financial Strength and Clinical Advancements Lead to Buy RatingNovember 14, 2024 | markets.businessinsider.comCalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesNovember 13, 2024 | prnewswire.comCalciMedica Appoints Stephen Bardin as New CFONovember 9, 2024 | markets.businessinsider.comCalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial OfficerNovember 7, 2024 | prnewswire.comSanderling Venture Partners Vi Buys 86,867 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockNovember 6, 2024 | insidertrades.comCalciMedica’s Auxora Shows Promise in Acute Pancreatitis: Analyst Recommends BuyNovember 5, 2024 | markets.businessinsider.comCalciMedica price target lowered to $16 from $20 at H.C. WainwrightNovember 5, 2024 | markets.businessinsider.comA. Rachel Leheny Buys 20,000 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockNovember 2, 2024 | insidertrades.comCalciMedica (NASDAQ:CALC) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comCalciMedica announces common stock offering, no amount givenNovember 1, 2024 | markets.businessinsider.comCalciMedica Announces Pricing of Public Offering of Common StockOctober 30, 2024 | prnewswire.comCalciMedica Announces Proposed Public Offering of Common StockOctober 30, 2024 | prnewswire.comCalciMedica, Inc. (NASDAQ:CALC) Short Interest Down 9.3% in OctoberCalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 34,200 shares, a decrease of 9.3% from the September 30th total of 37,700 shares. Based on an average daily trading volume, of 35,500 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.8% of the company's stock are short sold.October 30, 2024 | marketbeat.comCalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific MeetingOctober 30, 2024 | prnewswire.comCalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)October 28, 2024 | prnewswire.comCalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific MeetingOctober 16, 2024 | prnewswire.comCalciMedica (NASDAQ:CALC) Trading Down 2%CalciMedica (NASDAQ:CALC) Stock Price Down 2%September 24, 2024 | marketbeat.comCalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | prnewswire.comDirector Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC)August 27, 2024 | finance.yahoo.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Insider Purchases 5,000 Shares of StockAugust 27, 2024 | insidertrades.comEric W. Roberts Purchases 5,000 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockAugust 23, 2024 | insidertrades.comCalciMedica, Inc.: CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesAugust 18, 2024 | finanznachrichten.deOppenheimer maintains target on CalciMedica stock, sees growth potentialAugust 16, 2024 | uk.investing.comOppenheimer Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS)August 13, 2024 | markets.businessinsider.comCalciMedica (NASDAQ:CALC) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $20.00 price target on shares of CalciMedica in a research note on Tuesday.August 13, 2024 | marketbeat.comCalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesAugust 12, 2024 | prnewswire.comCalciMedica, Inc. (CALC)July 20, 2024 | finance.yahoo.comCalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)July 9, 2024 | prnewswire.comCalciMedica Announces Presentations at Two Upcoming Healthcare Investment ConferencesJuly 8, 2024 | prnewswire.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Director Purchases 8,443 Shares of StockJuly 2, 2024 | insidertrades.comCalciMedica Set to Join Russell Microcap® IndexJuly 1, 2024 | prnewswire.comCalciMedica, Inc. (NASDAQ:CALC) Insider Buys $16,100.00 in StockJune 29, 2024 | insidertrades.comCalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)June 27, 2024 | prnewswire.com Remove Ads Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address CALC Media Mentions By Week CALC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CALC News Sentiment▼0.970.78▲Average Medical News Sentiment CALC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CALC Articles This Week▼41▲CALC Articles Average Week Remove Ads Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Coya Therapeutics News Coherus BioSciences News Milestone Pharmaceuticals News Fate Therapeutics News Procaps Group News Nkarta News XBiotech News Silence Therapeutics News Immunic News Galectin Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CALC) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CALC Stock Free CALC Stock Alerts